{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:01:09Z","timestamp":1791874869311,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["P01 HL160470"],"award-info":[{"award-number":["P01 HL160470"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08 DK-117064"],"award-info":[{"award-number":["K08 DK-117064"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001424","name":"American Liver Foundation","doi-asserted-by":"publisher","award":["ALF-2023-LS-002-20500"],"award-info":[{"award-number":["ALF-2023-LS-002-20500"]}],"id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["R01 HL168569"],"award-info":[{"award-number":["R01 HL168569"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["R01 HL166214"],"award-info":[{"award-number":["R01 HL166214"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["HL 166418"],"award-info":[{"award-number":["HL 166418"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["R01 HL158054"],"award-info":[{"award-number":["R01 HL158054"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jhepr.2025.101549","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:28:37Z","timestamp":1754954917000},"page":"101549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adipose microsomal triglyceride transfer protein deficiency protects against hepatic steatosis by upregulating PPAR\u03b1 activity"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-0587","authenticated-orcid":false,"given":"Sujith","family":"Rajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Verano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4568-4296","authenticated-orcid":false,"given":"Thomas","family":"Palaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9930-4358","authenticated-orcid":false,"given":"Chandana","family":"Prakashmurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9385-101X","authenticated-orcid":false,"given":"Shahidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonisamy William","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3753-6717","authenticated-orcid":false,"given":"Jos\u00e9 O.","family":"Alem\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9802-143X","authenticated-orcid":false,"given":"Edward A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9663-300X","authenticated-orcid":false,"given":"M. Mahmood","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101549_bib1","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhepr.2025.101549_bib2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2025.101549_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and mechanisms of nonalcoholic fatty liver disease","volume":"78","author":"Haas","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jhepr.2025.101549_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1194\/jlr.R200014-JLR200","article-title":"Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly","volume":"44","author":"Hussain","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhepr.2025.101549_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jacl.2022.08.009","article-title":"Guidance for the diagnosis and treatment of hypolipidemia disorders","volume":"16","author":"Bredefeld","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jhepr.2025.101549_bib6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/MOL.0b013e328312707c","article-title":"New approaches to target microsomal triglyceride transfer protein","volume":"19","author":"Hussain","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jhepr.2025.101549_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101549_bib8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101549_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2025.101549_bib10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2025.101549_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/ijem.IJEM_585_17","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus","volume":"22","author":"Dharmalingam","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2025.101549_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.47162\/RJME.62.2.17","article-title":"Systemic and adipose tissue inflammation in NASH: correlations with histopathological aspects","volume":"62","author":"Micu","year":"2021","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.jhepr.2025.101549_bib13","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms15046184","article-title":"Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease","volume":"15","author":"Jung","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2025.101549_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease","volume":"7","author":"Chait","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jhepr.2025.101549_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.plipres.2010.10.004","article-title":"Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores","volume":"50","author":"Lass","year":"2011","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jhepr.2025.101549_bib16","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.1100747","article-title":"Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase","volume":"306","author":"Zimmermann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2025.101549_bib17","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.febslet.2005.05.009","article-title":"Microsomal triglyceride transfer protein expression in adipocytes: a new component in fat metabolism","volume":"579","author":"Swift","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jhepr.2025.101549_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155331","article-title":"Microsomal triglyceride transfer protein regulates intracellular lipolysis in adipocytes independent of its lipid transfer activity","volume":"137","author":"Rajan","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2025.101549_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100115","article-title":"A simple, rapid, and sensitive fluorescence-based method to assess triacylglycerol hydrolase activity","volume":"62","author":"Rajan","year":"2021","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhepr.2025.101549_bib20","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1194\/jlr.D400043-JLR200","article-title":"Transfer of cholesteryl esters and phospholipids as well as net deposition by microsomal triglyceride transfer protein","volume":"46","author":"Rava","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhepr.2025.101549_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-2003-41284","article-title":"Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia","volume":"111","author":"Julius","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jhepr.2025.101549_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jhepr.2025.101549_bib23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1210\/endo-107-2-584","article-title":"Increased formation of triglyceride from oleate in perfused livers from pregnant rats","volume":"107","author":"Wasfi","year":"1980","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhepr.2025.101549_bib24","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1136\/gutjnl-2017-313778","article-title":"Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase\/hydrogen sulfide pathway","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101549_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4020249","article-title":"An overview of lipid metabolism and nonalcoholic fatty liver disease","volume":"2020","author":"Pei","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jhepr.2025.101549_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/bj20020851","article-title":"Control of human carnitine palmitoyltransferase II gene transcription by peroxisome proliferator-activated receptor through a partially conserved peroxisome proliferator-responsive element","volume":"369","author":"Barrero","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.jhepr.2025.101549_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review","volume":"13","author":"Grygiel-Gorniak","year":"2014","journal-title":"Nutr J"},{"key":"10.1016\/j.jhepr.2025.101549_bib28","doi-asserted-by":"crossref","first-page":"26827","DOI":"10.1074\/jbc.272.43.26827","article-title":"Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha","volume":"272","author":"Ren","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhepr.2025.101549_bib29","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101549_bib30","article-title":"Removal of serum lipids and lipid-derived metabolites to investigate breast cancer cell biology","volume":"19","author":"Brovkovych","year":"2019","journal-title":"Proteomics"},{"key":"10.1016\/j.jhepr.2025.101549_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0022-2275(20)40226-3","article-title":"Separation of lipids by Silica Gel G column chromatography","volume":"5","author":"Crider","year":"1964","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhepr.2025.101549_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/cr.2010.13","article-title":"PPARs: diverse regulators in energy metabolism and metabolic diseases","volume":"20","author":"Wang","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.jhepr.2025.101549_bib33","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature07202","article-title":"Integration of metabolism and inflammation by lipid-activated nuclear receptors","volume":"454","author":"Bensinger","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2025.101549_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12944-017-0551-1","article-title":"Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study","volume":"16","author":"Feng","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jhepr.2025.101549_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101549_bib36","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1210\/jc.2019-00875","article-title":"Hepatic fatty acid balance and hepatic fat content in humans with severe obesity","volume":"104","author":"Lytle","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2025.101549_bib37","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2025.101549_bib38","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1210\/en.2015-1322","article-title":"Impact of reduced ATGL-mediated adipocyte lipolysis on obesity-associated insulin resistance and inflammation in male mice","volume":"156","author":"Schoiswohl","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhepr.2025.101549_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The role and regulation of the peroxisome proliferator activated receptor alpha in human liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.jhepr.2025.101549_bib40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1440-1746.2011.06939.x","article-title":"Peroxisome proliferator-activated receptor-alpha agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis","volume":"27","author":"Larter","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101549_bib41","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11745-004-1333-0","article-title":"Mechanisms of regulation of gene expression by fatty acids","volume":"39","author":"Nakamura","year":"2004","journal-title":"Lipids"},{"key":"10.1016\/j.jhepr.2025.101549_bib42","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cell.2009.05.036","article-title":"Identification of a physiologically relevant endogenous ligand for PPARalpha in liver","volume":"138","author":"Chakravarthy","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2025.101549_bib43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/mend.11.6.0007","article-title":"Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay","volume":"11","author":"Krey","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhepr.2025.101549_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101727","article-title":"PPARalpha ligand-binding domain structures with endogenous fatty acids and fibrates","volume":"23","author":"Kamata","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.jhepr.2025.101549_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/549627","article-title":"Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases","volume":"2013","author":"Monsalve","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jhepr.2025.101549_bib46","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jhep.2023.07.004","article-title":"Treating NASH by targeting peroxisome proliferator-activated receptors","volume":"79","author":"Staels","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101549_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-016-0061-6","article-title":"Mice subjected to aP2-Cre mediated ablation of microsomal triglyceride transfer protein are resistant to high fat diet induced obesity","volume":"13","author":"Bakillah","year":"2016","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.jhepr.2025.101549_bib48","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nm.2439","article-title":"ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1","volume":"17","author":"Haemmerle","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2025.101549_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110910","article-title":"ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARalpha activity","volume":"39","author":"Fougerat","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhepr.2025.101549_bib50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhep.2015.02.035","article-title":"Fasting-induced G0\/G1 switch gene 2 and FGF21 expression in the liver are under regulation of adipose tissue derived fatty acids","volume":"63","author":"Jaeger","year":"2015","journal-title":"J Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925002289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925002289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:35:32Z","timestamp":1773030932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925002289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2589555925002289"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101549","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipose microsomal triglyceride transfer protein deficiency protects against hepatic steatosis by upregulating PPAR\u03b1 activity","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101549"}}